bf/NASDAQ:SYNH_icon.jpeg

COM:SYNEOSHEALTH

Syneos Health

  • Stock

USD

Last Close

42.97

27/09 20:00

Market Cap

4.46B

Beta: -

Volume Today

6.70M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Mar '23
average inventory
12.49M
-
15.81M
26.59%
8.57M
45.83%
529.50K
93.82%
660.50K
24.74%
357K
45.95%
average payables
13.37M
-
13.07M
2.21%
19.52M
49.36%
23.09M
18.30%
41.13M
78.11%
78.60M
91.08%
117.66M
49.69%
125.19M
6.40%
110.61M
11.64%
113.08M
2.23%
average receivables
228.05M
-
238.60M
4.63%
273.19M
14.50%
341.68M
25.07%
700.67M
105.07%
1.14B
62.18%
1.28B
12.66%
1.32B
3.44%
1.43B
8.35%
1.59B
10.47%
book value per share
5.31
-
7.36
38.56%
3.76
48.95%
5.58
48.55%
40.35
623.13%
27.62
31.55%
29.24
5.87%
31.12
6.45%
32.85
5.56%
33.94
3.31%
capex per share
-0.34
-
-0.48
40.75%
-0.36
23.92%
-0.58
59.12%
-0.59
0.98%
-0.53
9.90%
-0.62
16.95%
-0.48
22.24%
-0.55
13.98%
-0.91
65.86%
capex to depreciation
-0.30
-
-0.47
54.63%
-0.38
19.55%
-0.53
40.51%
-0.24
53.93%
-0.20
18.23%
-0.26
32.27%
-0.22
14.76%
-0.24
7.26%
-0.38
56.74%
capex to operating cash flow
-0.48
-
-0.19
59.10%
-0.10
46.95%
-0.29
178.12%
-0.22
22.79%
-0.18
18.74%
-0.20
11.65%
-0.12
41.49%
-0.13
7.40%
-0.22
73.39%
capex to revenue
-0.02
-
-0.02
21.76%
-0.02
30.39%
-0.02
29.03%
-0.02
15.61%
-0.01
24.30%
-0.01
10.02%
-0.01
17.22%
-0.01
3.72%
-0.02
58.93%
cash per share
1.86
-
2.37
27.24%
1.47
38.10%
1.90
29.14%
4.29
126.12%
1.51
64.84%
1.58
4.77%
2.61
65.40%
1.03
60.77%
1.09
6.11%
days of inventory on hand
7.04
-
6.89
2.18%
0.16
97.67%
0.18
14.26%
0.13
30.79%
days payables outstanding
4.52
-
6.83
51.18%
8.00
17.05%
7.17
10.39%
10.42
45.46%
10.48
0.57%
13.68
30.55%
12.21
10.76%
9.83
19.53%
10.46
6.46%
days sales outstanding
83.94
-
76.90
8.38%
77.74
1.08%
87.33
12.34%
138.78
58.92%
104.49
24.71%
101.76
2.61%
111.16
9.23%
106.77
3.95%
111.34
4.28%
debt to assets
0.48
-
0.34
30.03%
0.41
22.83%
0.39
6.77%
0.41
6.87%
0.39
5.58%
0.39
0.50%
0.40
1.79%
0.37
6.24%
0.35
5.43%
debt to equity
2.15
-
1.07
50.25%
2.31
115.54%
1.65
28.47%
1.00
39.73%
0.99
0.51%
0.96
2.66%
0.99
2.90%
0.90
9.00%
0.83
8.08%
dividend yield
0.00
-
0.00
41.63%
earnings yield
-0.04
-
-0.02
56.02%
0.04
343.18%
0.04
4.92%
-0.04
206.98%
0.01
114.08%
0.02
256.94%
0.03
27.53%
0.02
18.95%
0.07
220.45%
enterprise value
1.56B
-
1.66B
6.38%
3.22B
93.95%
3.24B
0.38%
5.95B
83.88%
6.74B
13.24%
8.92B
32.29%
10.04B
12.58%
13.64B
35.85%
6.56B
51.87%
enterprise value over ebitda
15.30
-
11.12
27.32%
14.78
32.97%
14.76
0.19%
18.63
26.25%
11.59
37.76%
15.73
35.66%
17.37
10.41%
20.78
19.66%
9.38
54.87%
ev to operating cash flow
41.94
-
12.65
69.84%
15.75
24.52%
29.61
87.98%
30.02
1.40%
22.21
26.01%
28.00
26.05%
23.60
15.74%
30.29
28.37%
15.37
49.25%
ev to sales
1.57
-
1.41
10.20%
2.30
63.39%
2.01
12.79%
2.23
10.83%
1.54
31.07%
1.91
24.21%
2.27
19.21%
2.62
15.07%
1.22
53.48%
free cash flow per share
0.38
-
1.99
428.38%
3.17
59.66%
1.44
54.50%
2.06
42.77%
2.41
16.78%
2.46
2.07%
3.60
46.75%
3.79
5.08%
3.24
14.49%
free cash flow yield
0.02
-
0.08
321.43%
0.07
15.44%
0.03
58.04%
0.05
72.25%
0.06
29.40%
0.04
32.46%
0.05
28.10%
0.04
30.28%
0.09
139.37%
graham net net
-13.09
-
-9.98
23.78%
-11.83
18.61%
-11.02
6.90%
-42.44
285.28%
-31.91
24.81%
-31.68
0.73%
-33.99
7.28%
-34.41
1.25%
-32.61
5.23%
graham number
9.77
-
8.54
12.59%
13.07
53.10%
16.18
23.75%
40.96
153.22%
12.08
70.51%
28.87
138.98%
36.00
24.71%
40.88
13.55%
44.46
8.75%
income quality
-0.90
-
-5.60
524.06%
1.75
131.23%
0.97
44.51%
-1.43
247.50%
12.50
972.74%
2.43
80.58%
2.21
9.04%
1.92
13.12%
1.60
16.44%
intangibles to total assets
0.64
-
0.60
6.85%
0.58
2.96%
0.52
11.11%
0.77
47.92%
0.75
1.59%
0.71
5.22%
0.71
0.85%
0.71
0.39%
0.68
3.54%
0
100%
interest coverage
0.52
-
1.20
131.93%
9.74
711.80%
12.93
32.72%
-0.45
103.50%
1.23
370.56%
2.50
103.98%
3.23
29.03%
4.92
52.49%
4.99
1.46%
interest debt per share
12.60
-
8.87
29.56%
8.94
0.73%
9.43
5.54%
41.00
334.59%
28.61
30.23%
29.43
2.87%
31.73
7.83%
30.41
4.18%
28.94
4.84%
inventory turnover
51.85
-
53.00
2.23%
2.27K
4,186.70%
1.99K
12.48%
2.87K
44.49%
invested capital
2.15
-
1.07
50.25%
2.31
115.54%
1.65
28.47%
1.00
39.73%
0.99
0.51%
0.96
2.66%
0.99
2.90%
0.90
9.00%
0.83
8.08%
market cap
1.07B
-
1.37B
28.49%
2.81B
105.08%
2.84B
1.21%
3.27B
14.93%
4.07B
24.59%
6.16B
51.43%
7.10B
15.17%
10.67B
50.28%
3.78B
64.59%
net current asset value
-580.72M
-
-425.98M
26.65%
-571.74M
34.22%
-464.40M
18.77%
-2.84B
511.77%
-2.91B
2.31%
-2.86B
1.54%
-3.08B
7.73%
-3.06B
0.81%
-2.76B
9.74%
net debt to ebitda
4.87
-
1.96
59.69%
1.91
2.64%
1.80
5.72%
8.41
366.66%
4.60
45.34%
4.86
5.77%
5.09
4.72%
4.53
11.01%
3.98
12.10%
net income per share
-0.80
-
-0.44
44.86%
2.02
559.19%
2.08
3.10%
-1.85
188.67%
0.23
112.70%
1.27
439.45%
1.85
46.10%
2.26
22.16%
2.59
14.47%
operating cash flow per share
0.72
-
2.47
244.14%
3.54
43.42%
2.02
42.79%
2.65
30.79%
2.93
10.87%
3.07
4.75%
4.08
32.90%
4.33
6.13%
4.15
4.35%
payables turnover
80.77
-
53.43
33.85%
45.65
14.57%
50.94
11.59%
35.02
31.25%
34.82
0.56%
26.67
23.40%
29.89
12.06%
37.15
24.27%
34.89
6.07%
receivables turnover
4.35
-
4.75
9.14%
4.70
1.07%
4.18
10.98%
2.63
37.07%
3.49
32.82%
3.59
2.68%
3.28
8.45%
3.42
4.11%
3.28
4.11%
research and ddevelopement to revenue
return on tangible assets
-0.09
-
-0.05
50.20%
0.23
590.82%
0.18
21.68%
-0.08
144.76%
0.01
116.74%
0.06
353.69%
0.08
32.94%
0.10
18.12%
0.10
5.09%
revenue per share
19.13
-
22.12
15.59%
24.17
9.29%
29.81
23.32%
35.67
19.66%
42.45
19.02%
45.13
6.30%
42.39
6.06%
50.19
18.39%
52.37
4.36%
roe
-0.15
-
-0.06
60.20%
0.54
999.57%
0.37
30.60%
-0.05
112.26%
0.01
118.56%
0.04
409.56%
0.06
37.25%
0.07
15.72%
0.08
10.81%
roic
0.05
-
0.07
33.65%
0.19
190.46%
0.16
13.76%
-0.01
103.61%
0.01
301.54%
0.07
463.73%
0.04
38.73%
0.04
4.13%
0.05
19.77%
sales general and administrative to revenue
0.09
-
shareholders equity per share
5.31
-
7.36
38.56%
3.76
48.95%
5.58
48.55%
40.35
623.13%
27.62
31.55%
29.24
5.87%
31.12
6.45%
32.85
5.56%
33.94
3.31%
stock based compensation to revenue
0.00
-
0.00
17.60%
0.00
26.84%
0.01
140.05%
0.02
156.65%
0.01
65.00%
0.01
50.98%
0.01
12.22%
0.01
5.57%
0.01
15.10%
tangible asset value
-518.21M
-
-355.01M
31.49%
-487.91M
37.44%
-365.51M
25.09%
-2.56B
599.30%
-2.61B
2.14%
-2.29B
12.14%
-2.47B
7.58%
-2.40B
2.84%
-2.08B
13.10%
tangible book value per share
-9.96
-
-6.66
33.15%
-8.43
26.55%
-6.76
19.74%
-34.12
404.37%
-25.24
26.01%
-22.14
12.31%
-23.69
7.01%
-23.08
2.56%
-20.23
12.35%
working capital
58.17M
-
47.10M
19.03%
-52.55M
211.56%
55.90M
206.39%
262.62M
369.78%
-11.24M
104.28%
45.70M
506.76%
160.68M
251.58%
112.34M
30.09%
219.25M
95.16%

All numbers in USD (except ratios and percentages)